Symbols

MYGN

Myriad Genetics·NASDAQ

--(--)

6.04 / 10

Outperform

Sentiment is Outperform (6.04) and fund‑flow score 7.91 (good). Overall and block inflows are positive, extra‑large investors are strong, while small, medium and large flows are negative. Analyst consensus is neutral (2 analysts). Capital moves favor larger players, but mixed sentiment tempers optimism.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Buy

Hold

Sell

Strong Sell

Date2026-02-24

InstitutionWells Fargo

Times predicted3

Historical Win Rate33.3%

What is the market sentiment for MYGN?

MYGN holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.04/10 (Outperform).